• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人细胞色素 P45051 被抗真菌唑类药物抑制的结构基础。

Structural basis of human CYP51 inhibition by antifungal azoles.

机构信息

Structural Genomics Consortium, University of Toronto, 101 College Street, Toronto, Ontario, Canada.

出版信息

J Mol Biol. 2010 Apr 9;397(4):1067-78. doi: 10.1016/j.jmb.2010.01.075. Epub 2010 Feb 10.

DOI:10.1016/j.jmb.2010.01.075
PMID:20149798
Abstract

The obligatory step in sterol biosynthesis in eukaryotes is demethylation of sterol precursors at the C14-position, which is catalyzed by CYP51 (sterol 14-alpha demethylase) in three sequential reactions. In mammals, the final product of the pathway is cholesterol, while important intermediates, meiosis-activating sterols, are produced by CYP51. Three crystal structures of human CYP51, ligand-free and complexed with antifungal drugs ketoconazole and econazole, were determined, allowing analysis of the molecular basis for functional conservation within the CYP51 family. Azole binding occurs mostly through hydrophobic interactions with conservative residues of the active site. The substantial conformational changes in the B' helix and F-G loop regions are induced upon ligand binding, consistent with the membrane nature of the protein and its substrate. The access channel is typical for mammalian sterol-metabolizing P450 enzymes, but is different from that observed in Mycobacterium tuberculosis CYP51. Comparison of the azole-bound structures provides insight into the relative binding affinities of human and bacterial P450 enzymes to ketoconazole and fluconazole, which can be useful for the rational design of antifungal compounds and specific modulators of human CYP51.

摘要

真核生物甾醇生物合成中的强制性步骤是甾醇前体在 C14 位的脱甲基化,这由 CYP51(甾醇 14-α脱甲基酶)在三个连续反应中催化。在哺乳动物中,该途径的最终产物是胆固醇,而重要的中间体减数分裂激活甾醇则由 CYP51 产生。已确定三种人 CYP51 的晶体结构,即无配体和与抗真菌药物酮康唑和依康唑结合的结构,从而分析了 CYP51 家族内功能保守的分子基础。唑类结合主要通过与活性位点保守残基的疏水相互作用发生。配体结合后,B' 螺旋和 F-G 环区域会发生实质性的构象变化,这与该蛋白及其底物的膜性质一致。该进入通道是典型的哺乳动物甾醇代谢 P450 酶,但与结核分枝杆菌 CYP51 观察到的不同。唑类结合结构的比较提供了对人源和细菌 P450 酶与酮康唑和氟康唑相对结合亲和力的深入了解,这对于合理设计抗真菌化合物和人 CYP51 的特异性调节剂可能是有用的。

相似文献

1
Structural basis of human CYP51 inhibition by antifungal azoles.人细胞色素 P45051 被抗真菌唑类药物抑制的结构基础。
J Mol Biol. 2010 Apr 9;397(4):1067-78. doi: 10.1016/j.jmb.2010.01.075. Epub 2010 Feb 10.
2
Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.结核分枝杆菌细胞色素P450 14α-甾醇脱甲基酶(CYP51)与唑类抑制剂复合物的晶体结构
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3068-73. doi: 10.1073/pnas.061562898.
3
Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.通过与独特的细菌细胞色素P450同工型CYP102同源性对酿酒酵母羊毛甾醇14α-去甲基酶(CYP51)进行分子建模:两个相关系列抗真菌唑衍生物的定量构效关系(QSARs)
J Enzyme Inhib. 1999;14(3):175-92. doi: 10.3109/14756369909030315.
4
Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.结核分枝杆菌CYP130:晶体结构、生物物理特性及与抗真菌唑类药物的相互作用
J Biol Chem. 2008 Feb 22;283(8):5069-80. doi: 10.1074/jbc.M708734200. Epub 2007 Dec 18.
5
Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole.两种甾醇14α-脱甲基酶同源模型的分子设计及其与唑类抗真菌药酮康唑和联苯苄唑的相互作用。
J Comput Aided Mol Des. 2005 Mar;19(3):149-63. doi: 10.1007/s10822-005-3692-7.
6
Structural analyses of sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis.与唑类药物复合的甾醇14α-脱甲基酶的结构分析揭示了唑类介导的真菌甾醇生物合成抑制的分子基础。
J Biol Chem. 2017 Apr 21;292(16):6728-6743. doi: 10.1074/jbc.M117.778308. Epub 2017 Mar 3.
7
A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.白色念珠菌羊毛甾醇14α-去甲基酶的三维模型及其与唑类抗真菌药物的相互作用。
J Med Chem. 2000 Jun 29;43(13):2493-505. doi: 10.1021/jm990589g.
8
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).白色念珠菌甾醇 14α-去甲基酶(CaCYP51)的唑类结合特性。
Antimicrob Agents Chemother. 2010 Oct;54(10):4235-45. doi: 10.1128/AAC.00587-10. Epub 2010 Jul 12.
9
Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents.异源表达的人羊毛甾醇14α-去甲基酶(其他名称:P45014DM、CYP51、P45051)的特性以及唑类抗真菌剂对纯化的人源和白色念珠菌CYP51的抑制作用。
Yeast. 1999 Jun 30;15(9):755-63. doi: 10.1002/(SICI)1097-0061(19990630)15:9<755::AID-YEA417>3.0.CO;2-8.
10
X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).4,4'-二羟基二苯甲酮在甾醇14α-去甲基酶(CYP51)活性位点模拟甾醇底物的X射线结构
J Biol Chem. 2008 May 30;283(22):15152-9. doi: 10.1074/jbc.M801145200. Epub 2008 Mar 26.

引用本文的文献

1
Unique Structural Features Relate to Evolutionary Adaptation of Cytochrome P450 in the Abyssal Zone.独特的结构特征与深海区域细胞色素P450的进化适应性相关。
Int J Mol Sci. 2025 Jun 13;26(12):5689. doi: 10.3390/ijms26125689.
2
Fluorescence Lifetime-Based FRET Biosensors for Monitoring N Terminal Domain-Dependent Interactions of TDP-43 in Living Cells: A Novel Approach for ALS and FTD Drug Discovery.基于荧光寿命的FRET生物传感器用于监测活细胞中TDP-43的N端结构域依赖性相互作用:肌萎缩侧索硬化症和额颞叶痴呆药物发现的新方法
ACS Chem Neurosci. 2025 Jul 2;16(13):2450-2462. doi: 10.1021/acschemneuro.5c00266. Epub 2025 Jun 10.
3
N-Arylsulfonylated C-Homoaporphines as a New Class of Antiplatelet and Antimicrobial Agents.
N-芳基磺酰化C-高阿朴啡作为一类新型抗血小板和抗菌剂
ACS Med Chem Lett. 2024 Dec 23;16(1):116-125. doi: 10.1021/acsmedchemlett.4c00491. eCollection 2025 Jan 9.
4
An Insight into Rational Drug Design: The Development of In-House Azole Compounds with Antimicrobial Activity.深入了解合理药物设计:具有抗菌活性的内部唑类化合物的开发。
Antibiotics (Basel). 2024 Aug 13;13(8):763. doi: 10.3390/antibiotics13080763.
5
Druggable Sterol Metabolizing Enzymes in Infectious Diseases: Cell Targets to Therapeutic Leads.传染性疾病中的可成药性固醇代谢酶:治疗靶点到治疗先导物。
Biomolecules. 2024 Feb 20;14(3):249. doi: 10.3390/biom14030249.
6
Chemical profiling of volatile compounds of the essential oil of grey-leaved rockrose ( L.) and its antioxidant, anti-inflammatory, antibacterial, antifungal, and anticancer activity and .灰叶岩蔷薇(Cistus incanus L.)精油挥发性成分的化学剖析及其抗氧化、抗炎、抗菌、抗真菌和抗癌活性
Front Chem. 2024 Feb 15;12:1334028. doi: 10.3389/fchem.2024.1334028. eCollection 2024.
7
Shaping immune landscape of colorectal cancer by cholesterol metabolites.胆固醇代谢物重塑结直肠癌的免疫景观。
EMBO Mol Med. 2024 Feb;16(2):334-360. doi: 10.1038/s44321-023-00015-9. Epub 2024 Jan 2.
8
Molecular Cloning, Heterologous Expression, Purification, and Evaluation of Protein-Ligand Interactions of CYP51 of Azole-Resistant Fungal Strain.唑类抗性真菌菌株CYP51的分子克隆、异源表达、纯化及蛋白质-配体相互作用评估
Biomedicines. 2023 Oct 24;11(11):2873. doi: 10.3390/biomedicines11112873.
9
Naringenin-Capped Silver Nanoparticles Amalgamated Gel for the Treatment of Cutaneous Candidiasis.柚皮素包覆的银纳米粒子复合凝胶治疗皮肤念珠菌病。
AAPS PharmSciTech. 2023 May 25;24(5):126. doi: 10.1208/s12249-023-02581-0.
10
Structural modeling of cytochrome P450 51 from a deep-sea fish points to a novel structural feature in other CYP51s.深海鱼类细胞色素 P450 51 的结构建模指向其他 CYP51 中的一种新结构特征。
J Inorg Biochem. 2023 Aug;245:112241. doi: 10.1016/j.jinorgbio.2023.112241. Epub 2023 Apr 28.